ArticlePediatric blood & cancer2023

Feasibility of combining temsirolimus to vincristine, dactinomycin, cyclophosphamide, and vincristine and irinotecan chemotherapy for children with intermediate-risk rhabdomyosarcoma: A report from Children's Oncology Group.

Sapna Oberoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.